SUMMARY OF THE SUMMIT:
The years ahead have the potential to be significant for the microbiome medicines space due to important data readouts. The 2nd Annual Chardan Microbiome Medicines Summit will feature key public and private companies leading development efforts in the field and will cover a variety of approaches to therapeutically targeting the microbiome. The Summit will provide insights on how to navigate the key issues of an emerging space, as well as identify what is on the horizon for these novel and potentially transformative therapeutics.
- What different strategies are companies utilizing to therapeutically modify or harness the microbiome?
- What are the areas of greatest unmet need that may be more easily addressed by microbiome medicines?
- Are microbiome medicines coming of age? If so, what clinical data can we hope to see in 2020 and beyond?
- What might participants discuss at the 3rd Annual Chardan Microbiome Medicines Summit in 2021?
For more information about Chardan’s Microbiome Medicines Summit please email CorpAccess@chardan.com.